160388-55-6

Basic information

• Product Name: [4-(1H-PYRAZOL-1-YLMETHYL)PHENYL]METHANOL
• Synonyms: [4-(1H-PYRAZOL-1-YLMETHYL)PHENYL]METHANOL;benzenemethanol, 4-(1H-pyrazol-1-ylmethyl)-;[4-(1-pyrazolylmethyl)phenyl]methanol;[4-(pyrazol-1-ylmethyl)phenyl]methanol
• CAS NO: 160388-55-6
• Molecular Formula: C₁₁H₁₂N₂O
• Molecular Weight: 188.23
• Mol File: 160388-55-6.mol
• Article Data: 5

Chemical Properties

• Melting Point: 51 °C
• Boiling Point: 377.913°C at 760 mmHg
• Flash Point: 182.355°C
• Appearance: /
• Density: 1.138g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.592
• PKA: 14.34±0.10(Predicted)
• CAS DataBase Reference: [4-(1H-PYRAZOL-1-YLMETHYL)PHENYL]METHANOL(CAS DataBase Reference)
• NIST Chemistry Reference: [4-(1H-PYRAZOL-1-YLMETHYL)PHENYL]METHANOL(160388-55-6)
• EPA Substance Registry System: [4-(1H-PYRAZOL-1-YLMETHYL)PHENYL]METHANOL(160388-55-6)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 160388-55-6(Hazardous Substances Data)

Usage

General Description

[4-(1H-PYRAZOL-1-YLMETHYL)PHENYL]METHANOL is a chemical compound with a molecular formula C15H14N2O. It is a derivative of phenylmethanol with a pyrazole group attached to the phenyl ring. [4-(1H-PYRAZOL-1-YLMETHYL)PHENYL]METHANOL may have potential applications in pharmaceutical research and drug development due to its unique structural features and potential biological activities. It is important to note that further research and analysis are required to fully understand the properties and potential uses of this chemical compound. Additionally, proper safety precautions should be followed when handling and working with this substance.

InChI:InChI=1/C11H12N2O/c14-9-11-4-2-10(3-5-11)8-13-7-1-6-12-13/h1-7,14H,8-9H2

Upstream product

• 397328-86-8 methyl 4-((1H-pyrazol-1-yl)methyl)benzoate 
• 2417-72-3 Methyl 4-(bromomethyl)benzoate 
• 26496-94-6 Ethyl 4-(bromomethyl)benzoate 
• 288-13-1 NH-pyrazole 
• 16473-35-1 4-(hydroxymethyl)benzyl chloride 

Downstream Products

• 222720-87-8 1-[[4-(bromomethyl)phenyl]methyl]-1H-pyrazole 

Relevant articles and documents

THERAPEUTIC INHIBITORY COMPOUNDS

The invention provides compounds of Formula I and Formula II: A-B-C-D-E-F-G-J (I) C-D-E-F-G-J (II) wherein A, B, C, D, E, F, G, and J have any of the values defined in the specification, and salts thereof. The compounds are useful for inhibiting plasma kallikrein, and for treating a disease or condition in an animal where inhibition of plasma kallikrein is indicated.

PYRAZOLOPYRIDINE PYRAZOLOPYRIMIDINE AND RELATED COMPOUNDS

In one aspect this invention relates generally to compounds of Formula: and sub-formulas thereof, or a tautomer of each thereof, a pharmaceutically acceptable salt of each thereof, or a pharmaceutically acceptable solvate of each of the foregoing, where X1, L1, L3, and R3 are described herein.

Non-steroidal antiinflammatory agents. Synthesis and enzyme inhibition of 2-[4-(heteroarylmethyl)phenyl]propanoic acids and analogues

Some 2-[4-(heteroarylmethyl)phenyl]propanoic acids and phenylacetic and benzoic analogues have been synthesized. All above acids were tested for their inhibitory activity on lipoxygenase and cyclooxygenase, in comparison with NDGA and tolmetin. 2-[4-(Thie